PANDEMIC Bharat Biotech’s Covaxin gets approval for emergency use for children aged 2-18 years Oct 12, 2021
NATION PANDEMIC AIIMS Delhi: second dose trial of Covaxin on 2-6 years old children to take place Jul 23, 2021
COVID-19 Vaccine: First batch of Russian candidate Sputnik-V to reach Kanpur for Phase 2 & 3 trials Nov 15, 2020
Oxford University COVID-19 Vaccine trials resume in the UK, India and Japan, but on hold in the US Oct 2, 2020
Brazil’s Bahia buys 50 million doses of Russian COVID-19 vaccine to conduct phase III trial Sep 11, 2020